Nephro Care India Limited (NSE:NEPHROCARE)

India flag India · Delayed Price · Currency is INR
112.35
+1.30 (1.17%)
At close: Feb 12, 2026
Market Cap1.85B -41.2%
Revenue (ttm)676.68M +148.5%
Net Income33.97M -23.0%
EPS2.06 -44.7%
Shares Out16.49M
PE Ratio54.49
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume10,400
Average Volume13,580
Open112.00
Previous Close111.05
Day's Range106.10 - 116.05
52-Week Range94.50 - 183.00
Betan/a
RSI58.67
Earnings DateFeb 13, 2026

About Nephro Care India

Nephro Care India Limited, provides treatment for kidney-related diseases in India. The company offers care for renal failure patients that include consultation, treatment, and yoga; nutritional support, including nutritional support for weight loss/weight gain, body composition analysis, anthropometry, and lifestyle education and support services for diabetic kidney disease, hypertensive nephropathy, glomerular disease, renal transplant recipient, hemodialysis patient, IgA nephropathy, lupus nephropathy, and ADPKD; and lifestyle and rehabilita... [Read more]

Industry Hospitals
Founded 2014
Employees 334
Stock Exchange National Stock Exchange of India
Ticker Symbol NEPHROCARE
Full Company Profile

Financial Performance

In fiscal year 2025, Nephro Care India's revenue was 460.31 million, an increase of 69.04% compared to the previous year's 272.31 million. Earnings were 36.39 million, a decrease of -17.51%.

Financial Statements